Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics development by Zuben E. Sauna, Vibha Jawa, Sathy Balu-Iyer, Narendra Chirmule

Get full text

Immunogenicity Risk Assessment of Spontaneously Occurring Therapeutic Monoclonal Antibody Aggregates by Michael D. Swanson, Shantel Rios, Sarita Mittal, George Soder, Vibha Jawa

Get full text

Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics. by Marisa K Joubert, Meghana Deshpande, Jane Yang, Helen Reynolds, Christine Bryson, Mark Fogg, Matthew P Baker, Jonathan Herskovitz, Theresa J Goletz, Lei Zhou, Michael Moxness, Gregory C Flynn, Linda O Narhi, Vibha Jawa

Get full text

Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper by Tong-yuan Yang, Manuela Braun, Wibke Lembke, Fraser McBlane, John Kamerud, Stephen DeWall, Edit Tarcsa, Xiaodong Fang, Lena Hofer, Uma Kavita, Vijay V. Upreti, Swati Gupta, LiNa Loo, Alison J. Johnson, Rakesh Kantilal Chandode, Kay-Gunnar Stubenrauch, Maya Vinzing, Cindy Q. Xia, Vibha Jawa

Get full text